Giving melanoma the one-two punch
Melanoma is a much more serious cancer, harder to treat and tends to progress more quickly. In 2017 alone, 7,300 people in Canada were diagnosed with melanoma; 1,240 died from it.
World Cancer Day 2019
On February 4th, BioCanRx is proud to take part in this global initiative aimed at making a commitment to a world without cancer. Across the country, the BioCanRx network is accelerating to the clinic Canada’s most promising and innovative cancer immunotherapies designed to save lives and enable a better quality of life.
Matchmaker, matchmaker, make me a match…
Jonathan Bramson’s lab at McMaster University had developed a new technology to produce immune cells that will attack multiple myeloma cells. Jean-Sébastien Delisle’s lab at the Université de Montréal had novel methods and capacity to manufacture human immune cells that target cancer cells and that persist for a long time in the body, providing sustained anti-cancer activity.